IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

October 13th 2024- Prof. Carlo Visco- More is Not Always Better

CME Congresses .

October 13th 2024- Prof. Carlo Visco- More is Not Always Better

October 6th 2024- Dr. Natalia Zing- The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T-and NK-cell lymphomas

CME Congresses .

October 6th 2024- Dr. Natalia Zing- The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T-and NK-cell lymphomas

September 30th 2024- Prof. Yves Chalandon- Nilotinib with or without Cytarabine for Philadelphia-positive Acute Lymphoblastic Leukemia

CME Congresses .

September 30th 2024- Prof. Yves Chalandon- Nilotinib with or without Cytarabine for Philadelphia-positive Acute Lymphoblastic Leukemia

September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy

CME Congresses .

September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy

September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis

CME Congresses .

September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis

September 2nd 2024- Prof. Mark Litzow- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

CME Congresses .

September 2nd 2024- Prof. Mark Litzow- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

August 26th 2024- Prof. Olaf Penack- How risky is a second allogeneic stem cell transplantation?

CME Congresses .

August 26th 2024- Prof. Olaf Penack- How risky is a second allogeneic stem cell transplantation?

July 22nd 2024- Dr. Kai Rejeski- A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

CME Congresses .

July 22nd 2024- Dr. Kai Rejeski- A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

July 16th 2024- Prof. Madhav Dhodapkar- Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

CME Congresses .

July 16th 2024- Prof. Madhav Dhodapkar- Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

July 7th 2024- Dr. Anand Patel- Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

CME Congresses .

July 7th 2024- Dr. Anand Patel- Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era